malaria

Social Business
0 Plan to produce synthetic anti-malaria drug criticized as “assault on farmers”

A decades’-long struggle to produce a synthetic version of one the world’s favored drugs for treating malaria, artemisinin, was celebrated as a victory for poor people. But now is being criticized as an assault on poor farmers. Global supply of artemisinin, which until now has been produced from harvest of the plant sweet wormwood, has been erratic in both quantity and supply. Hundreds of millions of people fall ill with malaria every year with an estimated 650,000 deaths — mostly in children.

The goal of this project, led by Seattle-based PATH in collaboration with the French drug firm Sanofi, was to supplement the global supply with this synthetic version. PATH officials told me that Sanofi’s ultimate production goal would likely only meet one-third of the global need, but the scientist who developed the synthetic drug said the goal is to totally replace dependence on the natural crop.

Social Business
0 PATH & Sanofi start major production of synthetic anti-malaria drug

Malaria remains one of the world’s biggest killers and also a massive economic drag on poor countries, poor families. One of our best weapons against this scourge is a drug known as artemisinin, which is harvested from the plant sweet wormwood and, as a crop, is about as predictable as corn or hog futures.A major new initiative to be launched tomorrow in Italy by Seattle-based PATH in collaboration with the French drug maker Sanofi aims to do industrial production of synthetic artemisinin.

Global Health
0 Uganda’s Health Minister on malaria, corruption and collaboration

Uganda’s been in the news a lot lately: An outbreak of deadly Ebola (now declared over). The country’s  celebration of its 50th anniversary of gaining independence from Britain (along with the perhaps less-celebrated 26th anniversary of President Yoweri Museveni’s refusal to relinquish power). The next phase of the bizarre “social-mediated”…

Science
0 ArsTechnica: The difficult search for a malaria vaccine

Seattle writer Robert Fortner, in ArsTechnica, examines how far we have come in the search for an effective malaria vaccine. This story is focused on what many consider the most promising malaria vaccine candidate, called RTS,S, made by GlaxoSmithKline decades ago and being tested (again) under improved formulations with funding…

Science
2 Infectious hope: When getting malaria makes sense

Flickr, Aya Rosen It’s World Malaria Day. There’s been great progress against malaria over the past decade but most experts agree the best hope is to find an effective vaccine. Seattle Biomed is one of the world leaders in malaria vaccine research, but testing these experimental vaccines relies on people…

1 2 3 4 5 7